Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - TOTAL LIABILITIES
Total Liabilities SPRO - Spero Therapeutics, Inc.
75.5 M
LAST VALUE
-4.50%
2 YEAR CAGR
41.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR